secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2022-09-07T23:59:59+00:00
Accession:  0001636422-22-000044
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst appoints new CRO as Chief Growth Officer; President Nelli transitions to Senior Advisor
--------------------------------------------------------------------------------

- Three new leadership appointments: Kevin Freeman as Chief Growth Officer, Tarah Neujahr Bryan as CMO, Dave Ross as CTO, effective Sept 7, 2022.
- President Patrick Nelli transitions to Senior Advisor effective Sept 30, 2022; departure is mutual, not due to disagreement.
- CTO Bryan Hinton to complete tenure on Sept 30, 2022.
- New growth leadership aligns with strategic focus on deepening client relationships and adding new clients.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642222000044/0001636422-22-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642222000044/a8-kxpnellideparture.htm
  HTML page:      https://secwatch.observer/filing/0001636422-22-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer